Literature DB >> 26934194

Accumulating evidence for a role of TCF7L2 variants in bipolar disorder with elevated body mass index.

Alfredo B Cuellar-Barboza1,2, Stacey J Winham3, Susan L McElroy4, Jennifer R Geske3, Gregory D Jenkins3, Colin L Colby3, Miguel L Prieto1,5,6, Euijung Ryu3, Julie M Cunningham7, Mark A Frye1, Joanna M Biernacka1,3.   

Abstract

OBJECTIVES: Bipolar disorder (BD) is a complex disease associated with various hereditary traits, including a higher body mass index (BMI). In a prior genome-wide association study, we found that BMI modified the association of rs12772424 - a common variant in the gene encoding transcription factor 7-like 2 (TCF7L2) - with risk for BD. TCF7L2 is a transcription factor in the canonical Wnt pathway, involved in multiple disorders, including diabetes, cancer and psychiatric conditions. Here, using an independent sample, we evaluated 26 TCF7L2 single nucleotide polymorphisms (SNPs) to explore further the association of BD with the TCF7L2-BMI interaction.
METHODS: Using a sample of 662 BD cases and 616 controls, we conducted SNP-level and gene-level tests to assess the evidence for an association between BD and the interaction of BMI and genetic variation in TCF7L2. We also explored the potential mechanism behind the detected associations using human brain expression quantitative trait loci (eQTL) analysis.
RESULTS: The analysis provided independent evidence of an rs12772424-BMI interaction (p = 0.011). Furthermore, while overall there was no evidence for SNP marginal effects on BD, the TCF7L2-BMI interaction was significant at the gene level (p = 0.042), with seven of the 26 SNPs showing SNP-BMI interaction effects with p < 0.05. The strongest evidence of interaction was observed for rs7895307 (p = 0.006). TCF7L2 expression showed a significant enrichment of association with the expression of other genes in the Wnt canonical pathway.
CONCLUSIONS: The current study provides further evidence suggesting that TCF7L2 involvement in BD risk may be regulated by BMI. Detailed, prospective assessment of BMI, comorbidity, and other possible contributing factors is necessary to explain fully the mechanisms underlying this association.
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  TCF7L2; bipolar disorder; body mass index; obesity

Mesh:

Substances:

Year:  2016        PMID: 26934194     DOI: 10.1111/bdi.12368

Source DB:  PubMed          Journal:  Bipolar Disord        ISSN: 1398-5647            Impact factor:   6.744


  12 in total

1.  Genetic Risk Score Analysis in Early-Onset Bipolar Disorder.

Authors:  Peter S Jensen; Mark A Frye; Joanna M Biernacka; Paul E Croarkin; Joan L Luby; Kelly Cercy; Jennifer R Geske; Marin Veldic; Matthew Simonson; Paramjit T Joshi; Karen Dineen Wagner; John T Walkup; Malik M Nassan; Alfredo B Cuellar-Barboza; Leah Casuto; Susan L McElroy
Journal:  J Clin Psychiatry       Date:  2017 Nov/Dec       Impact factor: 4.384

2.  Association of Cytomegalovirus and Toxoplasma gondii Antibody Titers With Bipolar Disorder.

Authors:  Mark A Frye; Brandon J Coombes; Susan L McElroy; Lori Jones-Brando; David J Bond; Marin Veldic; Francisco Romo-Nava; William V Bobo; Balwinder Singh; Colin Colby; Michelle K Skime; Joanna M Biernacka; Robert Yolken
Journal:  JAMA Psychiatry       Date:  2019-12-01       Impact factor: 21.596

Review 3.  Neurodevelopmental Perspectives on Wnt Signaling in Psychiatry.

Authors:  Kimberly A Mulligan; Benjamin N R Cheyette
Journal:  Mol Neuropsychiatry       Date:  2017-01-13

4.  Casein kinase 1-epsilon deletion increases mu opioid receptor-dependent behaviors and binge eating1.

Authors:  L R Goldberg; S L Kirkpatrick; N Yazdani; K P Luttik; O A Lacki; R K Babbs; D F Jenkins; W E Johnson; C D Bryant
Journal:  Genes Brain Behav       Date:  2017-07-06       Impact factor: 3.449

5.  Shared Genetic Loci Between Body Mass Index and Major Psychiatric Disorders: A Genome-wide Association Study.

Authors:  Shahram Bahrami; Nils Eiel Steen; Alexey Shadrin; Kevin O'Connell; Oleksandr Frei; Francesco Bettella; Katrine V Wirgenes; Florian Krull; Chun C Fan; Anders M Dale; Olav B Smeland; Srdjan Djurovic; Ole A Andreassen
Journal:  JAMA Psychiatry       Date:  2020-05-01       Impact factor: 21.596

6.  Cytoplasmic FMR1-Interacting Protein 2 Is a Major Genetic Factor Underlying Binge Eating.

Authors:  Stacey L Kirkpatrick; Lisa R Goldberg; Neema Yazdani; R Keith Babbs; Jiayi Wu; Eric R Reed; David F Jenkins; Amanda F Bolgioni; Kelsey I Landaverde; Kimberly P Luttik; Karen S Mitchell; Vivek Kumar; W Evan Johnson; Megan K Mulligan; Pietro Cottone; Camron D Bryant
Journal:  Biol Psychiatry       Date:  2016-10-25       Impact factor: 13.382

Review 7.  The broad pathogenetic role of TCF7L2 in human diseases beyond type 2 diabetes.

Authors:  Laura Del Bosque-Plata; Eduardo Pavel Hernández-Cortés; Claudia Gragnoli
Journal:  J Cell Physiol       Date:  2021-10-06       Impact factor: 6.513

Review 8.  Wnt/β-catenin signaling in brain development and mental disorders: keeping TCF7L2 in mind.

Authors:  Joanna Bem; Nikola Brożko; Chaitali Chakraborty; Marcin A Lipiec; Kamil Koziński; Andrzej Nagalski; Łukasz M Szewczyk; Marta B Wiśniewska
Journal:  FEBS Lett       Date:  2019-06-30       Impact factor: 4.124

9.  Bipolar disorder with binge eating behavior: a genome-wide association study implicates PRR5-ARHGAP8.

Authors:  Susan L McElroy; Stacey J Winham; Alfredo B Cuellar-Barboza; Colin L Colby; Ada Man-Choi Ho; Hugues Sicotte; Beth R Larrabee; Scott Crow; Mark A Frye; Joanna M Biernacka
Journal:  Transl Psychiatry       Date:  2018-02-02       Impact factor: 6.222

10.  Evidence that genes involved in hedgehog signaling are associated with both bipolar disorder and high BMI.

Authors:  Claudia Pisanu; Michael J Williams; Diana M Ciuculete; Gaia Olivo; Maria Del Zompo; Alessio Squassina; Helgi B Schiöth
Journal:  Transl Psychiatry       Date:  2019-11-21       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.